Biased Ligands. Better Drugs.

Trevena, Inc. is a clinical stage biopharmaceutical company focused on discovering and developing biased ligands to deliver the next generation of GPCR targeted medicines

Using our proprietary platform, we have advanced three product candidates into development:

Copyright © Trevena, Inc.